← Back to CME filing summaryThis is the extracted source text from the SEC filing. Formatting may differ from the original document.
The disclosure under “Legal and Regulatory Matters” in Note 7. Contingencies in the Notes to Unaudited Consolidated Financial Statements in Item 1 of Part I of this report is incorporated herein by reference. Such disclosure includes updates to the legal proceedings disclosed in the company’s Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on February 26, 2026.